Related Experiment Videos

Update on the management of immune thrombocytopenic purpura in children

Michael D Tarantino1, Paula Hb Bolton-Maggs

  • 1Comprehensive Bleeding Disorders Center, Peoria, Illinois 61614, USA. mdtara@hemophilia-ctr-peoria.com

Insights

Current guidelines for childhood immune thrombocytopenic purpura (ITP) are evolving. While anti-D immune globulin is a front-line option, treatment decisions for minimally symptomatic children remain controversial, prompting new clinical tools.

Area of Science:

  • Pediatric Hematology
  • Immunology
  • Clinical Therapeutics

Background:

  • Management guidelines for immune thrombocytopenic purpura (ITP) in children have evolved since 1996 and 2003.
  • Recent literature continues to refine diagnostic and therapeutic approaches to childhood ITP.

Purpose of the Study:

  • To review recent advancements in the diagnosis and treatment of immune thrombocytopenic purpura in children.
  • To synthesize current evidence and ongoing debates in pediatric ITP management.

Main Methods:

  • Literature review of publications from the past decade.
  • Analysis of recent studies on diagnostic approaches and treatment strategies.
  • Evaluation of evidence for various therapeutic options, including anti-D immune globulin, rituximab, and splenectomy.

Main Results:

  • Diagnostic approaches for childhood ITP remain largely unchanged.
  • Anti-D immune globulin is confirmed as a first-line treatment option.
  • Rituximab shows promise for persistent disease, and splenectomy offers durable long-term effects.
  • Treatment decisions for minimally symptomatic children with severe thrombocytopenia are debated.

Conclusions:

  • The optimal management strategy for minimally symptomatic children with severe thrombocytopenia is still under investigation.
  • Clinical scoring and quality of life tools are being developed to aid treatment and trial design.
  • Adult ITP treatment experiences are informing new therapeutic options for children, particularly those with chronic or severe bleeding.
Abstract

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.